Abstract:Objective To investigate the incidence and risk factors of nocturnal hypoglycemia in type 1 diabetes mellitus (T1DM), and to explore whether nocturnal hypoglycemia can be evaluated by daily capillary blood glucose profiles. Methods A total of 137 T1DM patients hospitalized in Nanjing Drum Tower Hospital between May 2013 and August 2018 were recruited and received continuous glucose monitoring (CGM) for 3 consecutive days during stable therapy period, meanwhile capillary blood glucose measurements (before and after 3 meals as well as at bedtime) were recorded. From data of CGM, the patients were divided into nocturnal hypoglycemia group and non-hypoglycemia group. The demographics, laboratory measurements and dynamic blood glucose parameters were compared between these two groups. Receiver operating characteristic curve (ROC) was used to analyze the optimal cut-off points of fasting blood glucose, postprandial blood glucose, bedtime blood glucose and BGn was used to predict nocturnal hypoglycemia. Multiple regression analysis was used to evaluate the risk factors of nocturnal hypoglycemia. Results (1) Totally, 179 hypoglycemic profiles monitored by CGM were recorded in 137 patients with T1DM, including 50 nocturnal hypoglycemic episodes occurred in 31 patients (27.9%). (2) Logistic regression analysis indicated that glycated hemoglobin A1c (HbA1c), glycated albumin and mean blood glucose were independent negatively correlated with nocturnal hypoglycemia (OR=0.784, 0.021, 0.751, P<0.05), while standard deviation of blood glucose and low blood glucose index were independent positively correlated with nocturnal hypoglycemia (OR=1.641, 3.004, P<0.05). (3) Of the daily capillary blood glucose profiles, levels of fasting blood glucose, blood glucose after dinner and blood glucose at bedtime were independently negative correlated with nocturnal hypoglycemia (OR=0.257, 0.685, 0.708, P<0.05). The cut-off values for prediction of nocturnal hypoglycemia were as follows: levels of fasting glucose was 5.8 mmol/L [sensitivity 80%, specificity 90%, area under curvel (AUC) 0.91], levels of blood glucose after dinner was 8.2 mmol/L (sensitivity 57%, specificity 76%, AUC 0.72), levels of blood glucose at bedtime was 6.7 mmol/L (sensitivity 64%, specificity 90%, AUC 0.80). (4) Based on the capillary blood glucose profiles before meals and at bedtime, a model was established for the prediction of nocturnal hypoglycemia: BGn=bedtime blood glucose × (1-SDSM/MBGSM). When BGn was 5.2 mmol/L, the specificity increased to 93% and AUC was 0.81. Conclusion Nocturnal hypoglycemia is common in patients with T1DM, and individualized blood glucose control targets should be set. Potential increased risk factors of nocturnal hypoglycemia were as follows: the levels of fasting blood glucose in the morning is below 5.8 mmol/L, the levels of blood glucose at bedtime is below 6.7 mmol/L or the model of BGn is below 5.2 mmol/L. Key words: Type 1 diabetes; Nocturnal hypoglycemia; Capillary blood glucose monitoring; Continuous glucose monitoring

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

Prediction of Nocturnal Hypoglycemia From Continuous Glucose Monitoring Data in People With Type 1 Diabetes: A Proof-of-Concept Study

Bedtime Prediction of Nocturnal Hypoglycemia in Insulin-Treated Type 2 Diabetes Patients

Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awareness

Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring

Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections

Prediction of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes under Multiple Daily Injections Using Continuous Glucose Monitoring and Physical Activity Monitor

Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8

Prediction of Nocturnal Hypoglycaemia with Bedtime Glucose Level During Continuous Subcutaneous Insulin Infusion in Type 2 Diabetics

Alanine and Terbutaline in the Prevention of Nocturnal Hypoglycemia in IDDM

136-OR: Nocturnal Hypoglycemia Prevention Strategies Used by People with Type 1 Diabetes According to Their Insulin Delivery and Blood Glucose Monitoring Technology

Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus

Nighttime hypoglycemia in Japanese children with type 1 diabetes mellitus treated with multiple daily injection insulin therapy

Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis

Value of Daily Capillary Blood Glucose Profiles in Assessing Nocturnal Hypoglycemia of Type 1 Diabetes Mellitus Based on Continuous Blood Glucose Monitoring System

Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes

Machine Learning and Deep Learning Models for Nocturnal High- and Low-Glucose Prediction in Adults with Type 1 Diabetes

A comparison of the rates of clock-based nocturnal hypoglycemia and hypoglycemia whilst asleep among people living with diabetes: findings from the Hypo-METRICS study

Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring

Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial

An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulin